The Threefold Protrusions of Adeno-Associated Virus Type 8 Are Involved in Cell Surface Targeting as Well as Postattachment Processing

被引:45
作者
Raupp, Christina [1 ]
Naumer, Matthias [1 ]
Mueller, Oliver J. [2 ]
Gurda, Brittney L. [3 ]
Agbandje-McKenna, Mavis [3 ]
Kleinschmidt, Juergen A. [1 ]
机构
[1] German Canc Res Ctr, Res Program Infect & Canc, D-6900 Heidelberg, Germany
[2] Univ Heidelberg Hosp, Heidelberg, Germany
[3] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA
基金
美国国家卫生研究院;
关键词
GENE-THERAPY VECTORS; INNATE IMMUNE-RESPONSE; AAV-FACTOR-IX; VIRAL-VECTORS; IN-VIVO; LIVER TRANSDUCTION; HEPATIC EXPRESSION; NONHUMAN-PRIMATES; CAPSID PROTEINS; VISCERAL ORGANS;
D O I
10.1128/JVI.00209-12
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Adeno-associated virus (AAV) has attracted considerable interest as a vector for gene therapy owing its lack of pathogenicity and the wealth of available serotypes with distinct tissue tropisms. One of the most promising isolates for vector development, based on its superior gene transfer efficiency to the liver in small animals compared to AAV type 2 (AAV2), is AAV8. Comparison of the in vivo gene transduction of rAAV2 and rAAV8 in mice showed that single amino acid exchanges in the 3-fold protrusions of AAV8 in the surface loops comprised of residues 581 to 584 and 589 to 592 to the corresponding amino acids of AAV2 and vice versa had a strong influence on transduction efficiency and tissue tropism. Surprisingly, not only did conversion of AAV8 to AAV2 cap sequences increase the transduction efficiency and change tissue tropism but so did the reciprocal conversion of AAV2 to AAV8. Insertion of new peptide motifs at position 590 in AAV8 also enabled retargeting of AAV8 capsids to specific tissues, suggesting that these sequences can interact with receptors on the cell surface. However, a neutralizing monoclonal antibody that binds to amino acids (588)QQNTA(592) of AAV8 does not prevent cell binding and virus uptake, indicating that this region is not necessary for receptor binding but rather that the antibody interferes with an essential step of postattachment processing in which the 3-fold protrusion is also involved. This study supports a multifunctional role of the 3-fold region of AAV capsids in the infection process.
引用
收藏
页码:9396 / 9408
页数:13
相关论文
共 91 条
[81]   Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid:: Epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection [J].
Wobus, CE ;
Hügle-Dörr, B ;
Girod, A ;
Petersen, G ;
Hallek, M ;
Kleinschmidt, JA .
JOURNAL OF VIROLOGY, 2000, 74 (19) :9281-9293
[82]   Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism [J].
Wu, P ;
Xiao, W ;
Conlon, T ;
Hughes, J ;
Agbandje-McKenna, M ;
Ferkol, T ;
Flotte, T ;
Muzyczka, N .
JOURNAL OF VIROLOGY, 2000, 74 (18) :8635-8647
[83]   Gene therapy vectors based on adeno-associated virus type 1 [J].
Xiao, WD ;
Chirmule, N ;
Berta, SC ;
McCullough, B ;
Gao, GP ;
Wilson, JM .
JOURNAL OF VIROLOGY, 1999, 73 (05) :3994-4003
[84]   The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy [J].
Xie, Q ;
Bu, WS ;
Bhatia, S ;
Hare, J ;
Somasundaram, T ;
Azzi, A ;
Chapman, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (16) :10405-10410
[85]   Continuous CD8+ T-Cell Priming by Dendritic Cell Cross-Presentation of Persistent Antigen following Adeno-Associated Virus-Mediated Gene Delivery [J].
Xu, Dan ;
Walker, Christopher M. .
JOURNAL OF VIROLOGY, 2011, 85 (22) :12083-12086
[86]   Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library [J].
Ying, Y. ;
Mueller, O. J. ;
Goehringer, C. ;
Leuchs, B. ;
Trepel, M. ;
Katus, H. A. ;
Kleinschmidt, J. A. .
GENE THERAPY, 2010, 17 (08) :980-990
[87]   A muscle-targeting peptide displayed on AAV2 improves muscle tropism on systemic delivery [J].
Yu, C. -Y ;
Yuan, Z. ;
Cao, Z. ;
Wang, B. ;
Qiao, C. ;
Li, J. ;
Xiao, X. .
GENE THERAPY, 2009, 16 (08) :953-962
[88]   Immunity to adeno-associated virus vectors in animals and humans: a continued challenge [J].
Zaiss, A. K. ;
Muruve, D. A. .
GENE THERAPY, 2008, 15 (11) :808-816
[89]   The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice [J].
Zhu, Jiangao ;
Huang, Xiaopei ;
Yang, Yiping .
JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (08) :2388-2398
[90]   Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield [J].
Zolotukhin, S ;
Byrne, BJ ;
Mason, E ;
Zolotukhin, I ;
Potter, M ;
Chesnut, K ;
Summerford, C ;
Samulski, RJ ;
Muzyczka, N .
GENE THERAPY, 1999, 6 (06) :973-985